Bioassay for Dioxin and Dioxin-like Chemicals
Superfund Research Program
Halogenated aromatic hydrocarbons (HAHs), such as polychlorinated biphenyls (PCBs), dibenzo-p-dioxins, and dibenzofurans, are global environmental contaminants. They are present in wildlife, domestic animals, and human tissues as well as in food, water, and soil samples. Because of their ubiquitous distribution, resistance to degradation and high toxicity, these chemicals can have a significant impact on the health and well-being of humans and animals. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, "dioxin"), the most potent HAH, can produce species and tissue-specific toxic and biological effects including reproductive dysfunction, birth defects, endocrine disruption, impaired immune function and cancer.
With support from the SRP, Dr. Michael Denison at the University of California-Davis developed the Chemically-Activated LUciferase eXpression (CALUX®) system, a rapid and inexpensive recombinant cell bioassay system for the detection and relative quantitation of dioxin-like chemicals in sample extracts that is amenable for large scale screening analysis. The CALUX assay has been accepted by the international community of governments and, in 2008, was included in the US EPA’s Test Methods for Evaluating Solid Waste, Physical/Chemical Methods, known as SW-846.
What is SW-846?
The new CALUX bioassay has been provided to governmental, academic and commercial laboratories in six countries and is currently being evaluated for adoption as a validated screening method to detect the presence of these toxic chemicals in food and feed. From a Research Translation perspective new interest has been shown by companies who market analytical technology to food production and process businesses who analyze their commodities for these contaminants. The UC Davis Innovation Access technology transfer office has made this technology available for research and commercial licensing (see Amplified Recombinant Cell Bioassay For The Detection Of Dioxin And Related Ah Receptor Ligands ). Negotiations are under way to secure licenses for the marketing this technology.